Table 3 Results of the regression analysis of inappropriate use of SABA

Patient characteristics

Sex (female = 1)

0.95

0.94–0.97

<.0001

Socio economic score

0.98

0.97–0.98

<.0001

Year

0.95

0.95–0.95

<.0001

Age (per 10 years increase)

0.96

0.96–0.97

<.0001

Type and quality of care (Asthma attributable)

Pulmonary function test 

0.95

0.93–0.98

<.0001

Ratio of ICS to total medication more than 50%

0.30

0.29–0.30

<.0001

Respirologist consultation

0.71

0.68–0.74

<.0001

Cardiologist consultation

1.73

0.88–3.39

0.110

Internal medicine consultation 

0.78

0.75–0.81

<.0001

Allergist consultation

0.86

0.82–0.89

<.0001

General Practitioner visits

 No visit

0.56

0.55–0.56

<.0001

 1 visit PY (Reference  group)

–

– 

–

 2 visits PY

0.77

0.76–0.78

<.0001

 More than 2 visits

0.53

0.52–0.54

<.0001

Continuity of care (COC)

 COC = 0 (Reference group)

–

 –

–

 COC >0 and COC <50%

0.84

0.82–0.85

<.0001

 COC ≥50% and COC <100%

0.83

0.82–0.85

<.0001

 COC = 100%

0.85

0.83–0.87

<.0001

 Comorbidity (Asthma attributable events are excluded)

Number of hospitalizations

1.01

1.00–1.02

0.143

Number of physician visits

0.88

0.87–0.89

<.0001

Modified Charlson score

1.00

0.99–1.01

0.130